세계의 투석 기기 시장 : 인사이트·경쟁 환경·시장 예측(-2030년)

Dialysis Devices Market by Product Type (Hemodialysis Machines, Peritoneal Dialysis Machines, Continuous Renal Replacement Therapy Machines, and Consumables), Mobility (Stationary and Portable), End-User (Hospitals, Dialysis Centers, and Homecare Settings), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the increasing number of acute kidney injuries and the rising product developmental activities across the globe

The dialysis devices market was valued at USD 71.00 billion in 2023, growing at a CAGR of 4.84% during the forecast period from 2024 to 2030 to reach USD 94.30 billion by 2030. The dialysis devices market is experiencing significant growth due to the increasing instances of acute kidney injury and sepsis, coupled with advancements in technology and product launches which are acting as major factors contributing to the overall growth of the dialysis devices market during the forecast period from 2024 to 2030.

Dialysis Devices Market Dynamics:

As per data from the International Society of Nephrology 2021, each year, there are around 13.3 million cases of acute kidney injury (AKI) globally and the burden is more inclined towards emerging countries where the annual incidence is estimated to be 11.3 million. The rising prevalence of acute kidney injury (AKI), especially in emerging countries, is driving the demand for dialysis devices as healthcare systems face mounting pressure to manage kidney-related conditions. This increased incidence underscores the need for advanced, accessible dialysis solutions to provide timely treatment, fueling market growth and innovation in dialysis equipment technology globally.

According to the recently updated data in 2024 from the Global Sepsis Alliance, sepsis is a global health crisis that afflicts almost 47 to 50 million individuals each year. Dialysis devices are employed to manage sepsis to provide continuous renal support, helping regulate fluid balance, remove toxins, and support overall organ function.

In addition to this, the World Sepsis Day was initiated by the Global Sepsis Alliance in 2012. Each year on September 13th, events are held worldwide to raise awareness for sepsis. These events included activities for medical professionals, sports events, photo exhibitions, pink picnics, gala events, dinners, public gatherings such as open houses in hospitals and healthcare facilities, and various online events.

Moreover, in September 2024, Fresenius Medical Care announced that it launched the newest version of its home hemodialysis (HHD) machine, the NxStage Versi HD with GuideMe software.

Therefore, the factors stated above collectively will drive the overall dialysis devices market growth.

However, risks associated with the use of dialysis devices, alteration of electrolyte levels in the blood, and others may prove to be challenging factors for dialysis device market growth.

Dialysis Devices Market Segment Analysis:

Dialysis Devices Market by Product Type (Hemodialysis Machines, Peritoneal Dialysis Machines, Continuous Renal Replacement Therapy Machines and Consumables), Mobility (Stationary and Portable), End-User (Hospitals, Dialysis Centers, and Homecare Settings), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the dialysis devices market, the continuous renal replacement therapy machines category is expected to have a significant revenue share in the year 2023. This can be ascribed to several advantages offered by continuous renal replacement therapy machines.

Continuous renal replacement therapy (CRRT) machines offer several advantages, especially for critically ill patients with acute kidney injury in intensive care settings. CRRT machines provide a slow and continuous filtration process that more closely mimics natural kidney function, minimizing the risks associated with rapid fluid shifts. This gentler approach is beneficial for hemodynamically unstable patients, as it allows for better control of fluid removal and electrolyte balance over extended periods, reducing the likelihood of complications.

Additionally, CRRT is highly customizable, enabling healthcare providers to adjust parameters like fluid removal rate, dialysis dose, and solute clearance according to individual patient needs, which enhances its effectiveness and safety for patients in critical condition.

Therefore, the widespread uses and various features of continuous renal replacement therapy machines enhance performance and usability, solidifying the significant impact on the growth of the overall dialysis devices market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall dialysis devices market:

Among all the regions, North America is expected to dominate the dialysis devices market in the year 2023 and is expected to do the same during the forecast period. This can be attributed to several factors, including the prevalence of end-stage renal disease (ESRD), ongoing product development activities by regulatory authorities, and the availability of prompt and well-established healthcare facilities, supported by the presence of key players in the region that contribute to the growth of the dialysis devices market in the North America region during the forecast period from 2024 to 2030.

According to the US Department of Health and Human Services 2021, end-stage renal disease (ESRD) is a significant public health problem in the United States and a major source of suffering and poor quality of life for those afflicted. Dialysis devices provide continuous renal support, which is particularly beneficial for patients with severe symptoms or complications.

The prompt and well-established healthcare services and infrastructure further contribute to the growth of the regional dialysis devices market growth. The presence of key players such as B. Braun Melsungen AG, Medtronic, and Baxter with their strong distribution networks ensure widespread availability and accessibility of these devices across the region increasing their revenue shares in the market, and supportive reimbursement programs providing immense growth opportunities for the same.

Therefore, the interplay of all the aforementioned factors would provide a conducive growth environment for the North America dialysis devices market.

Dialysis Devices Market key players:

Some of the key market players operating in the dialysis devices market include Fresenius Medical Care, B. Braun Melsungen AG, Nipro Corporation, Dialife SA, Baxter, NIKKISO CO. LTD., Asahi Kasei Medical, NxStage Medical, Inc, Infomed SA, Medtronic, Anjue Medical Equipment Co., Ltd, Dialco Medical Inc, SWS Hemodialysis Care Co.,Ltd, TORAY MEDICAL CO,.LTD, QUANTA Dialysis Technologies., and others.

Recent Developmental Activities in the Dialysis Devices Market:

• In August 2023, Quanta Dialysis Technologies(R), a medical technology company dedicated to enhancing kidney care accessibility, announced the FDA 510(k) clearance for an expanded indication of the Quanta Dialysis System. This compact and user-friendly hemodialysis device was approved for use in continuous venovenous hemodialysis (CVVHD).
• In January 2021, the US Food and Drug Administration granted regulatory approval to Quanta Dialysis Technologies Ltd for their product- hemodialysis system SC+. The device is a portable system that is capable of offering dialysis care comparable to full-sized dialysis equipment in a range of care settings.

Key Takeaways from the Dialysis Devices Market Report Study

• Market size analysis for current dialysis devices market size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the dialysis devices market.
• Various opportunities available for other competitors in the dialysis devices market space
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current dialysis devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for dialysis devices market growth in the coming future?

Target Audience who can be benefited from this Dialysis Devices Market Report Study

• Dialysis device providers
• Research organizations and consulting companies
• Dialysis devices - related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in dialysis devices
• Various end-users who want to know more about the dialysis devices market and the latest technological developments in the dialysis devices market

Frequently Asked Questions for the Dialysis Devices Market:

1. What are dialysis devices?

• Dialysis devices are medical equipment and consumables that help in substituting for kidney function in events of kidney failure or compromised kidney function to compensate and remove toxins from the body.

2. What is the market for dialysis devices?

• The dialysis devices market was valued at USD 71.00 billion in 2023, growing at a CAGR of 4.84% during the forecast period from 2024 to 2030 to reach USD 94.30 billion by 2030.

3. What are the drivers for the dialysis devices market?

• The dialysis devices market is experiencing significant growth due to the increasing instances of acute kidney injury and sepsis, coupled with advancements in technology and product launches which are acting as major factors contributing to the overall growth of the dialysis devices market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the dialysis devices market?

• Some of the key market players operating in dialysis devices include Fresenius Medical Care, B. Braun Melsungen AG, Nipro Corporation, Dialife SA, Baxter, NIKKISO CO. LTD., Asahi Kasei Medical, NxStage Medical, Inc, Infomed SA, Medtronic, Anjue Medical Equipment Co., Ltd, Dialco Medical Inc, SWS Hemodialysis Care Co., Ltd, TORAY MEDICAL CO,. LTD, QUANTA Dialysis Technologies, and others.

5. Which region has the highest share in the dialysis devices market?

• Among all the regions, North America is expected to dominate the dialysis devices market in the year 2023 and is expected to do the same during the forecast period. This can be attributed to several factors, including the prevalence of end-stage renal disease (ESRD), ongoing product development activities by regulatory authorities, and the availability of prompt and well-established healthcare facilities, supported by the presence of key players in the region that contribute to the growth of the dialysis devices market in the North America region during the forecast period from 2024 to 2030.

Table of Contents

1. Dialysis Devices Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Dialysis Devices Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Dialysis Devices Market Key Factors Analysis

• 5.1. Dialysis Devices Market Drivers
  • 5.1.1. Rising number of acute kidney injuries
  • 5.1.2. Increasing product developmental activities
  • 5.1.3. Increasing prevalence of diabetes
• 5.2. Dialysis Devices Market Restraints and Challenges
  • 5.2.1. Risks associated with the use of dialysis devices
  • 5.2.2. Alteration of electrolyte levels in the blood
• 5.3. Dialysis Devices Market Opportunities
  • 5.3.1. Improving product design
  • 5.3.2. Improving access to dialysis services in emerging economies

6. Dialysis Devices Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Dialysis Devices Market Assessment

• 7.1. By Product Type
  • 7.1.1. Hemodialysis Machines
  • 7.1.2. Peritoneal Dialysis Machines
  • 7.1.3. Continuous Renal Replacement Therapy Machines
  • 7.1.4. Consumables
• 7.2. By Mobility
  • 7.2.1. Stationary
  • 7.2.2. Portable
• 7.3. By End-User
  • 7.3.1. Hospitals
  • 7.3.2. Dialysis Centers
  • 7.3.3. Homecare Settings
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. United States Dialysis Devices Market Size in USD million (2021-2030)
    • 7.4.1.2. Canada Dialysis Devices Market Size in USD million (2021-2030)
    • 7.4.1.3. Mexico Dialysis Devices Market Size in USD million (2021-2030)
  • 7.4.2. Europe
    • 7.4.2.1. France Dialysis Devices Market Size in USD million (2021-2030)
    • 7.4.2.2. Germany Dialysis Devices Market Size in USD million (2021-2030)
    • 7.4.2.3. United Kingdom Dialysis Devices Market Size in USD million (2021-2030)
    • 7.4.2.4. Italy Dialysis Devices Market Size in USD million (2021-2030)
    • 7.4.2.5. Spain Dialysis Devices Market Size in USD million (2021-2030)
    • 7.4.2.6. Rest of Europe Dialysis Devices Market Size in USD million (2021-2030)
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. China Dialysis Devices Market Size in USD million (2021-2030)
    • 7.4.3.2. Japan Dialysis Devices Market Size in USD million (2021-2030)
    • 7.4.3.3. India Dialysis Devices Market Size in USD million (2021-2030)
    • 7.4.3.4. Australia Dialysis Devices Market Size in USD million (2021-2030)
    • 7.4.3.5. South Korea Dialysis Devices Market Size in USD million (2021-2030)
    • 7.4.3.6. Rest of Asia-Pacific Dialysis Devices Market Size in USD million (2021-2030)
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. Middle East Dialysis Devices Market Size in USD million (2021-2030)
    • 7.4.4.2. Africa Dialysis Devices Market Size in USD million (2021-2030)
    • 7.4.4.3. South America Dialysis Devices Market Size in USD million (2021-2030)

8. Dialysis Devices Market Company and Product Profiles

• 8.1. Fresenius Medical Care
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. B. Braun Melsungen AG
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Nipro Corporation
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Dialife SA
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Baxter
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. NIKKISO CO. LTD.
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. Asahi Kasei Medical
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. NxStage Medical, Inc
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Infomed SA
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. Medtronic
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Anjue Medical Equipment Co., Ltd
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Dialco Medical Inc
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. SWS Hemodialysis Care Co.,Ltd
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. TORAY MEDICAL CO,.LTD
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. QUANTA Dialysis Technologies
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us